A comparative analysis of generics markets in five European countries
- 13 March 2000
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 51 (3) , 149-162
- https://doi.org/10.1016/s0168-8510(00)00061-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The new pharmaceutical policy in ItalyHealth Policy, 1998
- What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?Health Policy, 1998
- The German experience in reference pricingHealth Policy, 1998
- An Historical Survey of UK Government Measures to Control the NHS Medicines Expenditure from 1948 to 1996PharmacoEconomics, 1996
- A critical review of the remuneration systems for pharmacistsHealth Policy, 1996
- Consequences of Implementing a Drug Budget for Office-Based Physicians in GermanyPharmacoEconomics, 1996
- Cultural shift in Italy's drug policyThe Lancet, 1995
- Generic MedicinesPharmacoEconomics, 1995
- Recent Public Policies in The Netherlands to Control Pharmaceutical Pricing and ReimbursementPharmacoEconomics, 1994
- Bioequivalence requirements for generic productsPharmacology & Therapeutics, 1994